Raymond J. Furey is EVP, GC, CCO & Corp Sec of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 38,830 shares of RIGL, which is worth approximately $845,717. The most recent transaction as insider was on Feb 05, 2025, when has been sold 1,339 shares (Common Stock) at a price of $21.93 per share, resulting in proceeds of $29,364. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.8K
81.86% 3M change
81.86% 12M change
Total Value Held $845,717

Raymond J. Furey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2025
SELL
Open market or private sale
$29,364 $21.93 p/Share
1,339 Reduced 3.33%
38,830 Common Stock
Feb 04 2025
SELL
Open market or private sale
$30,292 $20.92 p/Share
1,448 Reduced 3.48%
40,169 Common Stock
Jan 29 2025
BUY
Grant, award, or other acquisition
-
19,717 Added 32.15%
41,617 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
209,000 Added 49.41%
214,000 Common Stock
RJF

Raymond J. Furey

EVP, GC, CCO & Corp Sec
South San Francisco, CA

Track Institutional and Insider Activities on RIGL

Follow RIGEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RIGL shares.

Notify only if
Any

Insider Trading

Get notified when an Rigel Pharmaceuticals Inc insider buys or sells RIGL shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to RIGEL PHARMACEUTICALS INC

Track Activities on RIGL